OptimizeRx to Participate in Upcoming September Conferences

Rhea-AI Summary

OptimizeRx Corp (Nasdaq: OPRX) announced its participation in three upcoming conferences this September. Management will attend the R.W. Baird Healthcare Conference in New York City on September 13, the Lake Street BIG6 Investor Conference on September 14, and the LifeSci Health Tech Symposium virtually on September 21. Presentations will cover the company's innovative point-of-care technology solutions aimed at helping patients manage their therapies. Interested parties can request in-person meetings through designated contacts.

ROCHESTER, Mich., Sept. 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that management will participate in the following September conferences on the following days:

• R.W. Baird Healthcare Conference, New York City, September 13
• Lake Street BIG6 Investor Conference, New York City, September 14
• LifeSci Health Tech Symposium, Virtual, September 21
  

Conference Details:

R.W. Baird Healthcare Conference Presentation:
Date:	Tuesday, September 13
Time:	10:15 AM ET

Management will also be available for in-person one-on-one meetings. To request a meeting or for more details about the conference please reach out to your institutional contact or email: bairdconferences@rwbaird.com.

Lake Street BIG6 Investor Conference:
Date:	Wednesday, September 14
Format:	1-x-1 Meetings

For more details about the conference or to request an in-person one-on-one meeting please contact: info@lakestreetcm.com or conference@lakestreetcm.com. 

LifeSci Health Tech Symposium Presentation:
Date:	Wednesday, September 21
Time:	10:00 AM ET

For more information about the event or request a virtual meeting please register here.

About OptimizeRx
OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through the most intelligent technology platform embedded within a proprietary digital point-of-care network, OptimizeRx helps patients start and stay on their medications.

For more information, follow the company on Twitter, LinkedIn or visit www.optimizerx.com. 

Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify these forward-looking statements. All statements that reflect the Company’s expectations, assumptions, projections, beliefs or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Company’s growth, business plans and future performance. These forward-looking statements are based on the Company’s current expectations and assumptions regarding the Company’s business, the economy, and other future conditions. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other risks summarized in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, its subsequent Quarterly Reports on Form 10-Q, and its other filings with the Securities and Exchange Commission.

OptimizeRx Contact 
Andy D’Silva, SVP Corporate Finance
adsilva@optimizerx.com

Media Relations Contact 
Kimberley Sirk
ksirk@optimizerx.com

Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC
arr@lifesciadvisors.com

FAQ

What conferences will OptimizeRx attend in September 2022?

OptimizeRx will attend the R.W. Baird Healthcare Conference on September 13, the Lake Street BIG6 Investor Conference on September 14, and the LifeSci Health Tech Symposium virtually on September 21.

What is the date and time of OptimizeRx's presentation at the R.W. Baird Healthcare Conference?

OptimizeRx's presentation at the R.W. Baird Healthcare Conference is scheduled for September 13 at 10:15 AM ET.

How can I request a meeting with OptimizeRx management during the conferences?

To request a meeting with OptimizeRx management, interested parties can contact their institutional representative or email the respective conference organizers.

What is OptimizeRx's focus in the healthcare market?

OptimizeRx focuses on providing point-of-care technology solutions that facilitate patient engagement and therapy adherence through its digital platform.

Where can I find more information about OptimizeRx?

More information about OptimizeRx can be found on their official website at www.optimizerx.com.